Jerrold Sendrow
Director/Board Member chez VIRPAX PHARMACEUTICALS, INC.
Fortune : 3 835 $ au 31/03/2024
Profil
Jerrold Sendrow is an Independent Director at Virpax Pharmaceuticals, Inc. since 2017.
Prior to this, he was a Director at SCILEX Pharmaceuticals, Inc. from 2014 to 2016.
He worked as an Accountant-Audit Departments at Peat Marwick Mitchell & Co. and as Head-Accountant at Touche Ross & Co. He also worked as an Accountant-Audit Departments at Touche Ross & Co. (Australia).
Mr. Sendrow completed his undergraduate degree from Adelphi University and Baruch College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/03/2024 | 900 ( 0,08% ) | 3 835 $ | 31/03/2024 |
Postes actifs de Jerrold Sendrow
| Sociétés | Poste | Début |
|---|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Director/Board Member | 01/01/2017 |
Anciens postes connus de Jerrold Sendrow
| Sociétés | Poste | Fin |
|---|---|---|
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Director/Board Member | 01/11/2016 |
| Touche Ross & Co. | Comptroller/Controller/Auditor | - |
| Touche Ross & Co. (Australia) | Comptroller/Controller/Auditor | - |
| Peat Marwick Mitchell & Co. | Comptroller/Controller/Auditor | - |
Formation de Jerrold Sendrow
| Adelphi University | Undergraduate Degree |
| Baruch College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
| Peat Marwick Mitchell & Co. | Commercial Services |
| Touche Ross & Co. | Commercial Services |
| Touche Ross & Co. (Australia) |
